Matt Sharpe
Analyst · JMP. Please go ahead.
Thanks, Marita, and thanks, Matt, for the question. I'll give you a little bit more color. So overall, as Maria said, we couldn't be more pleased with the performance of the supplemental and Group Benefits segment, including all the team members that support it, both from a growth perspective and the earnings diversification. These businesses bring to Horace Mann as Murray that commented on, but not only are we happy with this year's performance. We're also very excited about the outlook of these businesses. We expect these to be among our fastest growing businesses over the next several years. Let me give you a little bit more color on our performance for the worksite direct sales team, which is our individual products division we grew the individual supplemental agent team by 23% in 2023. The growth of the team directly correlates to our sales results. You can see this clearly in our production, more specifically, the agents we appointed over the last two years in 2022 and 2023 accounted for just south of 38% of our total sales in 2023. So in 2024, we continue to focus on the growth of this team and have added additional resources to sustain our momentum in that in the individual division worksite continued to make progress in cross-selling as well, contributing a modest 13% of the overall 2023 Horace Mann life sales. So we're really just getting started there on the employer side of the business, Matt, we're seeing similar results. The momentum in our growth business has started to show signs of acceleration. We continue to be really pleased with our distribution partners and how we align our mutual growth objectives couldn't be tighter there. The total number of covered lives increased over 6%. We introduced the Horace Mann voluntary group products to over 65 new school districts in the past year and across all lines of business in supplemental and group, we grew our covered lives by just under 50,000 participants, bringing the total lives that we cover as of December 31st of last year to just under 800,000 lives with our group products, core sales represented about 51% of our new sales in 2023. And the rest, we predominantly others who serve the community. Also, we also typically refer to it as other public looking ahead in 2024 and beyond, we continue to focus on expanding our benefit broker and consultant relationships to maintain our growth momentum. So overall, very happy with our results for 23, very excited by the growth prospects for 24 and beyond as we expand our distribution relationships and further our cross-sell capabilities. And that kind of gives you the color that I think you were looking for. Is there a follow-up?